Clarity Pharmaceuticals Ltd Stock
Stocks
CU6
AU0000165375
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
04:10:09 20/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 1.770 AUD | -3.54% |
|
-2.48% | -47.63% |
| Market Cap | 685M 457M 416M 385M 349M 654M 42.69B 4.66B 1.85B 23.07B 1.71B 1.68B 73.07B | P/E 2027 * |
-6x | P/E 2028 * | -6.14x |
|---|---|---|---|---|---|
| Enterprise Value | 616M 411M 375M 347M 314M 589M 38.43B 4.19B 1.66B 20.76B 1.54B 1.51B 65.78B | EV / Sales 2027 * |
224x | EV / Sales 2028 * | 24.3x |
| Free-Float |
78.88% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| CU6 | Delayed | |
| CLRPF | Delayed | ||
| 1F4 | Real-time | ||
| 1F4 | Delayed |
| 1 day | -3.54% | ||
| 1 week | -2.48% | ||
| Current month | +12.74% | ||
| 3 months | -32.44% | ||
| 6 months | -29.76% | ||
| Current year | -47.63% |
| 1 week | 1.74 | 1.97 | |
| 1 month | 1.34 | 2.35 | |
| Current year | 1.34 | 4.26 | |
| 1 year | 1.34 | 4.26 | |
| 3 years | 1.26 | 8.98 | |
| 5 years | 0.36 | 8.98 | |
| 10 years | 0.36 | 8.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michelle Parker
CEO | Chief Executive Officer | - | 11/10/2024 |
Matthew Harris
CEO | Chief Executive Officer | - | 01/01/2010 |
David Green
DFI | Director of Finance/CFO | - | 04/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Taylor
CHM | Chairman | - | 01/11/2013 |
Rosanne Robinson
BRD | Director/Board Member | - | 01/10/2010 |
Chris Roberts
BRD | Director/Board Member | 72 | 29/03/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 22/4/26 | Sell | Chief Executive Officer | 360,896 | 0.0969% | ||
| 28/11/25 | Free | Chief Operating Officer | 199,909 | 0.0537% | ||
| 28/11/25 | Free | Chief Operating Officer | 287,530 | 0.0773% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.54% | -2.48% | -52.55% | +33.08% | 457M | ||
| +0.19% | -3.96% | +54.92% | +69.15% | 65.42B | ||
| -0.56% | -2.85% | +6.28% | +89.35% | 58.91B | ||
| -1.53% | -1.29% | +24.04% | +84.04% | 55.24B | ||
| -0.97% | -3.91% | +12.98% | +113.88% | 45.66B | ||
| -2.83% | -7.58% | +15.21% | +22.34% | 41.29B | ||
| +3.61% | +2.63% | +21.96% | +46.39% | 36.82B | ||
| -0.24% | -9.59% | +126.05% | +647.44% | 34.48B | ||
| +0.09% | +1.51% | +78.85% | +57.66% | 32.5B | ||
| +20.58% | +22.35% | -29.03% | +482.03% | 31.69B | ||
| Average | +1.48% | -1.40% | +25.87% | +164.54% | 40B | |
| Weighted average by Cap. | +1.27% | -0.99% | +33.01% | +153.43% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2.75M 1.84M 1.67M 1.55M 1.4M 2.63M 171M 18.72M 7.42M 92.65M 6.89M 6.74M 293M | 24.23M 16.18M 14.74M 13.64M 12.34M 23.15M 1.51B 165M 65.42M 816M 60.69M 59.42M 2.59B |
| Net income | -116M -77.68M -70.78M -65.52M -59.27M -111M -7.26B -792M -314M -3.92B -291M -285M -12.42B | -118M -78.66M -71.67M -66.34M -60.01M -113M -7.35B -802M -318M -3.97B -295M -289M -12.57B |
| Net Debt | -68.3M -45.6M -41.54M -38.46M -34.79M -65.26M -4.26B -465M -184M -2.3B -171M -167M -7.29B | -95.9M -64.02M -58.33M -54M -48.84M -91.63M -5.98B -653M -259M -3.23B -240M -235M -10.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | $1.770 | -3.54% | 4,919,786 |
| 19/11/26 | $1.835 | +0.27% | 2,469,804 |
| 18/11/26 | $1.830 | -3.17% | 1,984,874 |
| 17/11/26 | $1.890 | +3.56% | 3,799,444 |
| 16/11/26 | $1.825 | +0.55% | 3,707,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CU6 Stock
Select your edition
All financial news and data tailored to specific country editions
















